Sep 8, 2010 | Instruments & Equipment, Laboratory News, Laboratory Pathology, Management & Operations
Advanced histology staining equipment will capture a greater market share There’s good news for anatomic pathologists in the forecast from one expert watching the U.S. market in equipment for clinical diagnostics. According to Winny Tan, Ph.D, a Senior Analyst with Frost & Sullivan, the increasing rate of cancer incidence in the U.S. will drive robust growth in tissue-based diagnostics. She predicts that revenues from that segment will more than double by 2016, growing from the $1.029...
